Clinical Trial Update: PTCy and ATG for MSD and MUD Transplants [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial evaluating post-transplant cyclophosphamide and anti-thymocyte globulin for matched sibling and matched unrelated donor stem ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Drugs mentioned

• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)
• Post-transplant cyclophosphamide (PTCy) (cyclophosphamide)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING